Bluebird Bio Gene Therapies Show Promise Against Deadly Anemias

Bluebird Bio ' s experimental gene therapy LentiGlobin is helping some paitiens two life-threatening forms of inherited anemia avoid blood transfusions.

Source: Forbes.com Healthcare News - June 15, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NASDAQ:BLUE Source Type: news